Disclosure:
ASE is committed to ensuring that its educational mission, and all accredited continuing educational programs provide a protected space to learn, teach, and engage in scientific discourse free from influence from organizations that may have an incentive to insert commercial bias into education.
While a monetary or professional affiliation with an ineligible company does not necessarily influence a speaker’s presentation, the Standards for Integrity and Independence in Accredited Continuing Education and policies of the ACCME require that all financial relationships with ineligible companies* be identified and mitigated prior to engaging in an accredited CE activity. In accordance with these policies, ASE actively identified relevant financial relationships between faculty in control of this accredited CE activity and ineligible companies and implemented mitigation strategies to eliminate any potential influence from persons or organizations that may have an incentive to insert commercial bias in this activity. (*Companies that are ineligible to be accredited in the ACCME System (“ineligible companies”) are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.)
The following faculty members have no relevant financial relationships with ineligible companies:
- Bonita Anderson, M. APPL. SC(Med Ultrasound), DMU(Cardiac), AMS, ACS, FASE
- Benjamin Eidem, MD, FASE
- Allison G. Hays, MD, FASE
- Steven Lester, MD, FASE
- Christina Luong, BSc, MD, MHSc, FASE
- G. Burkhard Mackensen, MD, PhD, FASE
- Sunil Mankad, MD, FASE
- Akhil Narang, MD, FASE
- Natesa Pandian, MD
- Thomas Ryan, MD, FASE
- Carole Warnes, MD
- William Zoghbi, MD, FASE
All relevant financial relationships with ineligible companies listed for the following faculty members have been mitigated:
- Renuka Jain, MD, FASE; GE Healthcare (Research Funding); Medtronic (Speaker/Speaker's Bureau, Consultant/Advisor)
- Roberto Lang, MD, FASE; Philips Healthcare, TOMTEC (Consultant/Advisor); Ultrasight (Research Funding)
- Jonathan R. Lindner, MD, FASE; GE Healthcare, Lantheus Imaging, NASA, NIH (Research Funding/Support); BioMarin Pharma, Lantheus Medical Imaging, Cytokinetics, NovaPulse, Vibrato Inc. (Consultant/Advisor)
- Sharon Mulvagh, MD, FRCPC, FASE, FACC, FAHA; Lantheus, Novo Nordisk (Consultant/Advisor)
- Dermot Phelan, MD, PhD, FASE; Bristol Myers Squibb (Speaker/Speaker's Bureau); Caption Health (Consultant/Advisor)
- Gregory Scalia, MBBS, FASE - Abbott, Edwards, Philips, GE Healthcare (Speaker/Speaker's Bureau)
- James Thomas, MD, FASE - Abbott, Caption Health, egnite, GE Healthcare, EcchIQ (Consultant/Advisor)
Members of the ASE CME Committee members (not serving as faculty) do not have any financial relationships with ineligible companies. Click here for a list of these members.
None of the ASE staff who were involved in the planning and implementation of this educational activity have relevant financial relationship(s) to disclose with ineligible companies. Click here for a list of ASE staff members.